- Home
- Taking on heart disease
Innovating in Health&Care
“There’s a growing need to expand the CLTI treatment toolbox”
With new innovations in treating chronic limb-threatening ischemia (CLTI), surgeons are able to modify lesions that were, historically, too challenging to cross.
Do you know what heart failure is? (Hint: It’s probably not what you think)
Learn about the advances Johnson & Johnson is making to help turn heart failure into heart recovery for the millions of adults in the U.S. living with the condition, which occurs when the heart muscle isn’t able to pump blood as well as it should.
Inside the all-female coronary interventions trial
EMPOWER CAD is a first-of-its-kind study to determine the effectiveness of IVL in women to address a gender gap in coronary artery disease outcomes—and empower female clinicians along the way.
What’s the difference between a heart attack and cardiac arrest?
Both are life-threatening heart-health emergencies, but they are two distinct conditions with different causes and treatment. Here’s what a cardiologist wants you to know.
Ask an electrophysiologist: What roles do PFA and RFA play in the treatment of AFib?
Both are types of cardiac ablation, but are distinct in a few key ways. An expert weighs in on when and how they can be harnessed.
More from Johnson & Johnson
What you need to know about Johnson & Johnson’s 2025 third-quarter earnings
Here’s an infographic breakdown of the company’s third-quarter earnings results, including key highlights from its Innovative Medicine and MedTech businesses.
How Johnson & Johnson is helping healthcare providers remotely monitor and support patient health
Expertise, innovation and insight are fueling the development of remote and AI-powered approaches to healthcare—potentially improving treatment decisions and evolving the way clinical trials are designed and managed.
“Patients are the center of everything": Meet the scientist leader dedicated to developing effective IBD treatments
Her natural curiosity, determination and fascination with science inspired Esi Lamousé, M.D., Ph.D., to pursue a career that’s helped bring innovative therapies for inflammatory bowel disease to patients in need around the world.